ATE382684T1 - Avipox-vektor, der für ein hiv-antigen und gamma- interferon kodiert. - Google Patents

Avipox-vektor, der für ein hiv-antigen und gamma- interferon kodiert.

Info

Publication number
ATE382684T1
ATE382684T1 AT99957232T AT99957232T ATE382684T1 AT E382684 T1 ATE382684 T1 AT E382684T1 AT 99957232 T AT99957232 T AT 99957232T AT 99957232 T AT99957232 T AT 99957232T AT E382684 T1 ATE382684 T1 AT E382684T1
Authority
AT
Austria
Prior art keywords
hiv antigen
gamma interferon
vector coding
avipox vector
avipox
Prior art date
Application number
AT99957232T
Other languages
English (en)
Inventor
Stephen Kent
Ian Ramshaw
David Boyle
Original Assignee
Virax Dev Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virax Dev Pty Ltd filed Critical Virax Dev Pty Ltd
Application granted granted Critical
Publication of ATE382684T1 publication Critical patent/ATE382684T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99957232T 1998-11-09 1999-11-09 Avipox-vektor, der für ein hiv-antigen und gamma- interferon kodiert. ATE382684T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP7007A AUPP700798A0 (en) 1998-11-09 1998-11-09 Recombinant viral constructs and methods relating thereto

Publications (1)

Publication Number Publication Date
ATE382684T1 true ATE382684T1 (de) 2008-01-15

Family

ID=3811220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99957232T ATE382684T1 (de) 1998-11-09 1999-11-09 Avipox-vektor, der für ein hiv-antigen und gamma- interferon kodiert.

Country Status (10)

Country Link
US (1) US7276242B1 (de)
EP (1) EP1129177B1 (de)
JP (2) JP4596647B2 (de)
AT (1) ATE382684T1 (de)
AU (1) AUPP700798A0 (de)
CA (1) CA2350127C (de)
DE (1) DE69937900T2 (de)
HK (1) HK1040417B (de)
NZ (1) NZ511567A (de)
WO (1) WO2000028003A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544780B1 (en) * 2000-06-02 2003-04-08 Genphar, Inc. Adenovirus vector with multiple expression cassettes
JP5052732B2 (ja) * 2000-08-14 2012-10-17 アメリカ合衆国 遺伝的免疫化のための免疫原性を強化するＨＩＶＥｎｖ、Ｇａｇ、およびＰｏｌの改変
WO2002102404A1 (en) * 2001-06-18 2002-12-27 Institut National De La Recherche Agronomique Uses of cytokines
AU2004281298B2 (en) * 2003-10-15 2010-05-13 Virax Development Pty Ltd Poxvirus vector encoding retrovirus (eg HIV) and cytokine
NZ546443A (en) * 2003-10-15 2009-11-27 Virax Dev Pty Ltd Poxvirus vector encoding retrovirus (eg HIV) and cytokine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
DE3751664T2 (de) * 1986-08-01 1996-06-05 Commw Scient Ind Res Org Rekombinanter impfstoff
US5866136A (en) * 1986-08-01 1999-02-02 Commonwealth Scientific And Industrial Organisation Recombinant vaccine
AU672581B2 (en) * 1991-03-07 1996-10-10 Virogenetics Corporation Immunodeficiency virus recombinant poxvirus vaccine
US5766598A (en) * 1991-03-07 1998-06-16 Virogenetics Corporation Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products

Also Published As

Publication number Publication date
CA2350127C (en) 2011-01-04
EP1129177A4 (de) 2005-04-13
EP1129177B1 (de) 2008-01-02
DE69937900D1 (de) 2008-02-14
JP2010279361A (ja) 2010-12-16
CA2350127A1 (en) 2000-05-18
AUPP700798A0 (en) 1998-12-03
JP2002529076A (ja) 2002-09-10
JP4596647B2 (ja) 2010-12-08
EP1129177A1 (de) 2001-09-05
HK1040417B (en) 2008-07-18
NZ511567A (en) 2003-09-26
HK1040417A1 (en) 2002-06-07
US7276242B1 (en) 2007-10-02
DE69937900T2 (de) 2009-01-02
WO2000028003A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
TR200100056T2 (tr) Nörotrofik faktörler
FI951138A7 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
CY1109659T1 (el) Mva που εκφραζει τροποποιημενα γονιδια φακελλου, gag και pol του ιου hiv
ATE347057T1 (de) Federelement
MY129773A (en) An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine
CY1109531T1 (el) Πρωτεϊνες συντηξης του μυκοβακτηριδιου της φυματιωσης
MXPA02007478A (es) Vacuna contra el virus de inmunodeficiencia humana.
CY1109221T1 (el) Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
DE69937900D1 (de) Avipox-vektor, der für ein hiv-antigen und gamma-interferon kodiert.
ATE229345T1 (de) Cdna klon für den südafrikanischen arbovirus no.86
AU5322800A (en) Cloned genone of infectious hepatitis c virus of genotype 2a and uses thereof
DE3789252D1 (de) ROM-Fassung für Ausrufempfänger und andere.
IT1219701B (it) Poliammine parzialmente sostituite con 4,6 bis (n,n bis(2,2,6,6 tetrametil 4 piperdil) ammino) 1,3,5-triazin-2-il
ATE419306T1 (de) Alkoxysilylfunktionelle materialien auf siliconbasis
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
DE50109022D1 (de) Dentalmassen mit verringerter temperatursensibilität
ATE208421T1 (de) Stimulierung der immunantwort durch virales protein
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
ATE412753T1 (de) Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür
DE60026666D1 (de) Induktion von antigen-spezifischen T-Zellen durch Interferon
DE50203469D1 (de) Vernetzbare massen auf der basis von organosiliciumverbindungen
DK183685A (da) Tandlaegearbejdsplads
FR2719313B1 (fr) Protéine majeure de leishmanies, acide nucléique codant pour cette protéine et leurs applications.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1129177

Country of ref document: EP